Cargando…

The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma

Isocitrate dehydrogenase (IDH) mutation status is an important biomarker in the glioma-defining subtype and corresponding prognosis. This study proposes a straightforward method for 2-hydroxyglutarate (2-HG) quantification by MR spectroscopy for IDH mutation status detection and directly compares in...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dijken, Bart R. J., Jeltema, Hanne-Rinck, Kłos, Justyna, van Laar, Peter Jan, Enting, Roelien H., Maatman, Ronald G. H. J., Bijsterveld, Klaas, Den Dunnen, Wilfred F. A., Dierckx, Rudi A., Sijens, Paul E., van der Hoorn, Anouk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487112/ https://www.ncbi.nlm.nih.gov/pubmed/37685329 http://dx.doi.org/10.3390/diagnostics13172791

Ejemplares similares

Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More?
por: van Dijken, Bart R. J., et al.
Publicado: (2023)

Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma
por: van Dijken, Bart R. J., et al.
Publicado: (2021)

Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques
por: van Dijken, Bart R.J., et al.
Publicado: (2018)

Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients
por: de Groot, Jesse D., et al.
Publicado: (2023)

Degradation of D-2-hydroxyglutarate in the presence of isocitrate dehydrogenase mutations
por: Berger, Raffaela S., et al.
Publicado: (2019)

In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists
por: Kim, Hyeonjin, et al.
Publicado: (2016)

(11)C-methyl-L-methionine PET measuring parameters for the diagnosis of tumour progression against radiation-induced changes in brain metastases
por: Govaerts, Chris W., et al.
Publicado: (2021)

Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma
por: van Dijken, Bart R. J., et al.
Publicado: (2022)

Inter-observer reproducibility of quantitative dynamic susceptibility contrast and diffusion MRI parameters in histogram analysis of gliomas
por: Dijkstra, Hildebrand, et al.
Publicado: (2019)

Consequences of oncogenic isocitrate dehydrogenase mutations and 2-hydroxyglutarate production in prostate epithelium
por: Over, Jon A, et al.
Publicado: (2013)

Comparing navigated transcranial magnetic stimulation mapping and “gold standard” direct cortical stimulation mapping in neurosurgery: a systematic review
por: Jeltema, Hanne-Rinck, et al.
Publicado: (2020)

Iatrogenic encephalocele: a rare complication of vacuum extraction delivery
por: Jeltema, Hanne-Rinck, et al.
Publicado: (2011)

Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis
por: van Dijken, Bart R. J., et al.
Publicado: (2017)

2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP(+)-Dependent Isocitrate Dehydrogenase Mutations
por: Jin, Genglin, et al.
Publicado: (2011)

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
por: Gross, Stefan, et al.
Publicado: (2010)

2-Hydroxyglutarate Metabolism Is Altered in an in vivo Model of LPS Induced Endotoxemia
por: Fitzpatrick, Susan F., et al.
Publicado: (2020)

Intracerebral Distribution of the Oncometabolite d-2-Hydroxyglutarate in Mice Bearing Mutant Isocitrate Dehydrogenase Brain Tumors: Implications for Tumorigenesis
por: Pickard, Amanda J., et al.
Publicado: (2016)

Study on intracranial meningioma using PET ligand investigation during follow-up over years (SIMPLIFY)
por: Jeltema, Hanne-Rinck, et al.
Publicado: (2021)

D-2-Hydroxyglutarate producing neo-enzymatic activity inversely correlates with frequency of the type of isocitrate dehydrogenase 1 mutations found in glioma
por: Pusch, Stefan, et al.
Publicado: (2014)

Low pH Facilitates Heterodimerization of Mutant Isocitrate Dehydrogenase IDH1-R132H and Promotes Production of 2-Hydroxyglutarate
por: Sesanto, Rae, et al.
Publicado: (2021)

Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcome
por: van der Weide, Hiska L., et al.
Publicado: (2022)

Progress in understanding 2-hydroxyglutaric acidurias
por: Kranendijk, Martijn, et al.
Publicado: (2012)

The Roles of 2-Hydroxyglutarate
por: Du, Xin, et al.
Publicado: (2021)

The application of fluorescence techniques in meningioma surgery—a review
por: Dijkstra, Bianca M., et al.
Publicado: (2018)

The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo
por: Suijker, Johnny, et al.
Publicado: (2015)

Urine 2-Hydroxyglutarate in Glioma
por: Lombardi, Giuseppe, et al.
Publicado: (2016)

2-Hydroxyglutarate in Cancer Cells
por: Ježek, Petr
Publicado: (2020)

The current status of 5-ALA fluorescence-guided resection of intracranial meningiomas—a critical review
por: Motekallemi, Arash, et al.
Publicado: (2015)

Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach
por: Conroy, Siobhan, et al.
Publicado: (2014)

Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate
por: Andronesi, Ovidiu C., et al.
Publicado: (2018)

The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas
por: Reiter-Brennan, Cara, et al.
Publicado: (2018)

D-2-Hydroxyglutarate in Glioma Biology
por: Chou, Fu-Ju, et al.
Publicado: (2021)

Functional MRI for Treatment Evaluation in Patients with Head and Neck Squamous Cell Carcinoma: A Review of the Literature from a Radiologist Perspective
por: Nooij, Roland P., et al.
Publicado: (2018)

Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with head and neck tumors, a systematic review and meta-analysis
por: van der Hoorn, Anouk, et al.
Publicado: (2017)

D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells
por: Ugele, Ines, et al.
Publicado: (2019)

Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed
por: Zwart, Aniek T., et al.
Publicado: (2020)

The validation of low-dose CT scans from the [(18)F]-FDG PET-CT scan to assess skeletal muscle mass in comparison with diagnostic neck CT scans
por: Zwart, Aniek T., et al.
Publicado: (2023)

The sodium-dependent di- and tricarboxylate transporter, NaCT, is not responsible for the uptake of D-, L-2-hydroxyglutarate and 3-hydroxyglutarate into neurons
por: Brauburger, Katja, et al.
Publicado: (2011)

Radiologically Defined Sarcopenia as a Biomarker for Frailty and Malnutrition in Head and Neck Skin Cancer Patients
por: Zwart, Aniek T., et al.
Publicado: (2023)

Return of meningeal symptoms in a patient treated for cryptococcal meningitis
por: Huits, Ralph M. H. G., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_0gj2c3kususg10nmerpgvuu3ie